Here are five things to know:
1. The market totaled $508.1 million last year.
2. The report expects the market to hit $915.6 million by 2021, increasing at a compound annual growth rate of 12.5 percent.
3. Factors spurring market growth include increased use of fluorescence image-guided surgery, a higher demand for minimally invasive procedures, more surgeries, technological and facility advancements as well as customized microscope solutions.
4. The microscopes’ escalated price and the U.S. excise tax are impeding market growth. High custom duties on medical devices may also hinder expansion.
5. The neuro and spine surgery segment held the largest market share in 2016.
More articles on quality & infection control:
The 4 things payers can do to improve patient outcomes
Trump commends drug execs efforts, but says prices need to fall: 5 points
Implementing antibiotic prescription controls lowered C. diff. infections by 80% in England: 4 key points
